The judge said a 2022 law that prevented pharmacists from contacting patients about the efficacy of ivermectin and ...

The US Centers for Disease Control and Prevention (CDC) is warning people planning to travel to the Region of the Indian ...

San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work ...

From the anti-vaccine movement and COVID denialism to the promotion of raw pet food, the wellness-industrial complex has ...

India's health statistics in 2021, including excess deaths, HDI rise, and improved mortality rates, analyzed and discussed ...

Overall, the hazard ratio for in-hospital mortality at 28 days was 0.73 (95% confidence interval, 0.56 to 0.96) compared to ...

The Department of Health and Human Services’ mass dismissals of workers who release government records “raise grave transparency, accountability, and privacy concerns,” Oregon Sen. Ron Wyden said ...

Upon suspension of the trading of its Common Stock on Nasdaq, the Company expects that its Common Stock will be quoted under ...

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that had been developing a treatment for non-alcoholic steatohepatitis ...

The administration of U.S. President Donald Trump is making life difficult for academics and scientific researchers. Many are looking to leave the country as a result. We spoke with four of them.

The administration of U.S. President Donald Trump is making life difficult for academics and scientific researchers. Many are looking to leave the country as a result. We spoke with four of them.